Literature DB >> 1333990

Thrombin-induced proliferation and expression of platelet-derived growth factor-A chain gene in human vascular smooth muscle cells.

C Kanthou1, G Parry, E Wijelath, V V Kakkar, C Demoliou-Mason.   

Abstract

Treatment of human vascular smooth muscle cells (SMC) with human alpha-thrombin greatly increased DNA synthesis and cell proliferation. Both the integrity of the catalytic site and that of the anion binding exosite were required for expression of this activity. Experiments employing Northerns indicated induction of c-fos expression as well as a time-dependent induction of platelet-derived growth factor-A (PDGF-A) gene by thrombin. The thrombin mitogenic activity was potentiated by PDGF-BB, insulin and the vasoconstrictor peptide endothelin-1 suggesting synergism by convergence of intracellular growth-promoting signals. SMC treatment with pertussis toxin and forskolin indicated that the mitogenic activity of thrombin may be induced via signal transduction mechanism(s) involving changes in cAMP levels and activation of a Gi-like protein. These results suggest that thrombin may play a functional role in the regulation of human vascular SMC proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333990     DOI: 10.1016/0014-5793(92)80961-f

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Exogenous thrombin delivery promotes collateral capillary arterialization and tissue reperfusion in the murine spinotrapezius muscle ischemia model.

Authors:  Anthony C Bruce; Shayn M Peirce
Journal:  Microcirculation       Date:  2012-02       Impact factor: 2.628

2.  Effect of recombinant growth factors on human saphenous vein smooth muscle cells.

Authors:  P Dunlop; K Porter; K Varty; P Bell; N London
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.416

3.  Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells.

Authors:  E Bretschneider; R Kaufmann; M Braun; G Nowak; E Glusa; K Schrör
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

4.  Identification of a thrombin receptor with factor Xa receptor and tissue factor in human pancreatic carcinoma cells.

Authors:  A K Kakkar; N R Lemoine; S R Stone; D Altieri; R C Williamson
Journal:  Clin Mol Pathol       Date:  1995-10

5.  Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia.

Authors:  Nozomi Fukai; Richard D Kenagy; Lihua Chen; Lu Gao; Guenter Daum; Alexander W Clowes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

6.  Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture.

Authors:  P R Tomlinson; J W Wilson; A G Stewart
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

Review 7.  Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy.

Authors:  Junru Wang; Marjan Boerma; Qiang Fu; Martin Hauer-Jensen
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

8.  Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist.

Authors:  C J Molloy; J E Pawlowski; D S Taylor; C E Turner; H Weber; M Peluso
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

9.  Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells.

Authors:  O Benzakour; C Formstone; S Rahman; C Kanthou; U Dennehy; M F Scully; V V Kakkar; D N Cooper
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

10.  Evaluation of the use of the luciferase-reporter-gene system for gene-regulation studies involving cyclic AMP-elevating agents.

Authors:  O Benzakour; C Kanthou; U Dennehy; A al Haq; L P Berg; V V Kakkar; D N Cooper
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.